{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:58:26Z","timestamp":1788260306957,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clnesp.2023.10.013","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T15:20:02Z","timestamp":1697901602000},"page":"311-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial"],"prefix":"10.1016","volume":"58","author":[{"given":"Helda","family":"Tutunchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrangiz","family":"Ebrahimi-Mameghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Hosseinzadeh-Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Roshanravan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Mobasseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Najafipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Naeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Naghshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-7624","authenticated-orcid":false,"given":"Moloud","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Soleimanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ostadrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2023.10.013_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int : official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.clnesp.2023.10.013_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndrome"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.013_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2023.10.013_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101115","article-title":"Hepatic lipid droplets: a balancing act between energy storage and metabolic dysfunction in NAFLD","volume":"50","author":"Mashek","year":"2021","journal-title":"Mol Metabol"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.013_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13578-020-00507-y","article-title":"Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease","volume":"10","author":"Li","year":"2020","journal-title":"Cell Biosci"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.013_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/03670244.2021.1875453","article-title":"Food insecurity and lipid profile abnormalities are associated with an increased risk of nonalcoholic fatty liver disease (NAFLD): a case-control study","volume":"60","author":"Tutunchi","year":"2021","journal-title":"Ecol Food Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.013_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13104-020-05059-5","article-title":"The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults","volume":"13","author":"Tutunchi","year":"2020","journal-title":"BMC Res Notes"},{"issue":"18","key":"10.1016\/j.clnesp.2023.10.013_bib8","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.clnesp.2023.10.013_bib9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7150\/ijbs.19370","article-title":"Emerging roles of SIRT1 in fatty liver diseases","volume":"13","author":"Ding","year":"2017","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.clnesp.2023.10.013_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/B978-0-12-407766-9.00016-X","article-title":"Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism","volume":"91","author":"Kemper","year":"2013","journal-title":"Vitam Horm"},{"issue":"6993","key":"10.1016\/j.clnesp.2023.10.013_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature02583","article-title":"Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma","volume":"429","author":"Picard","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.clnesp.2023.10.013_bib12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/MCB.00705-08","article-title":"SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes","volume":"29","author":"Yoshizaki","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clnesp.2023.10.013_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fendo.2018.00614","article-title":"High levels of SIRT1 expression as a protective mechanism against disease-related conditions","volume":"9","author":"Elibol","year":"2018","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.clnesp.2023.10.013_bib14","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","article-title":"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha","volume":"26","author":"Gerhart-Hines","year":"2007","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.clnesp.2023.10.013_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113447","article-title":"PGC-1\u03b1 as a pivotal factor in lipid and metabolic regulation","volume":"19","author":"Cheng","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.013_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Cant\u00f3","year":"2009","journal-title":"Curr Opin Lipidol"},{"issue":"29","key":"10.1016\/j.clnesp.2023.10.013_bib17","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha","volume":"104","author":"J\u00e4ger","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.clnesp.2023.10.013_bib18","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.celrep.2017.03.011","article-title":"Liver-specific activation of AMPK prevents steatosis on a high-fructose diet","volume":"18","author":"Woods","year":"2017","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.clnesp.2023.10.013_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092826","article-title":"AMPK activation reduces hepatic lipid content by increasing fat oxidation in\u00a0vivo","volume":"19","author":"Foretz","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.013_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.celrep.2018.12.036","article-title":"Genetic liver-specific AMPK activation protects against diet-induced obesity and NAFLD","volume":"26","author":"Garcia","year":"2019","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.clnesp.2023.10.013_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.21614","article-title":"CCAAT\/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis","volume":"45","author":"Rahman","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clnesp.2023.10.013_bib22","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1210\/en.2005-1507","article-title":"Knocking down liver ccaat\/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db\/db mice","volume":"147","author":"Qiao","year":"2006","journal-title":"Endocrinology"},{"issue":"17","key":"10.1016\/j.clnesp.2023.10.013_bib23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1101\/gad.13.17.2231","article-title":"Activation and centromeric localization of CCAAT\/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation","volume":"13","author":"Tang","year":"1999","journal-title":"Gene Dev"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.013_bib24","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","author":"Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.013_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41574-021-00579-x","article-title":"Low brown adipose tissue activity linked to NAFLD","volume":"17","author":"Greenhill","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.013_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrendo.2016.136","article-title":"Brown adipose tissue as a secretory organ","volume":"13","author":"Villarroya","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.013_bib27","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JOE-19-0295","article-title":"New insights into the secretory functions of brown adipose tissue","volume":"243","author":"Villarroya","year":"2019","journal-title":"J\u00a0Endocrinol"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.013_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12952","article-title":"A\u00a0systematic review of the association of neuregulin 4, a brown fat-enriched secreted factor, with obesity and related metabolic disturbances","volume":"21","author":"Tutunchi","year":"2020","journal-title":"Obes Rev"},{"issue":"10","key":"10.1016\/j.clnesp.2023.10.013_bib29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/oby.22595","article-title":"Neuregulin 4: a \"hotline\" between Brown fat and liver","volume":"27","author":"Bl\u00fcher","year":"2019","journal-title":"Obesity"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.013_bib30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nm.3713","article-title":"The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.clnesp.2023.10.013_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14555","article-title":"Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): a case-control study","volume":"75","author":"Tutunchi","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.013_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12289","article-title":"Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity","volume":"9","author":"Wang","year":"2019","journal-title":"Clin Obes"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.013_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0041-1731704","article-title":"Management of obesity and nonalcoholic fatty liver disease: a literature review","volume":"41","author":"Hashem","year":"2021","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.013_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3945\/an.116.013730","article-title":"Nutritional approaches to achieve weight loss in nonalcoholic fatty liver disease","volume":"8","author":"Hsu","year":"2017","journal-title":"Adv Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.013_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/advances\/nmaa013","article-title":"The effects of diets enriched in monounsaturated oleic acid on the management and prevention of obesity: a systematic review of human intervention studies","volume":"11","author":"Tutunchi","year":"2020","journal-title":"Adv Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.013_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1440-1681.13238","article-title":"A\u00a0systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-\u03b1, on the management and prevention of obesity","volume":"47","author":"Tutunchi","year":"2020","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"27","key":"10.1016\/j.clnesp.2023.10.013_bib37","doi-asserted-by":"crossref","first-page":"27849","DOI":"10.1074\/jbc.M404087200","article-title":"Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha)","volume":"279","author":"Guzm\u00e1n","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.clnesp.2023.10.013_bib38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11745-008-3217-y","article-title":"Biological functions and metabolism of oleoylethanolamide","volume":"43","author":"Thabuis","year":"2008","journal-title":"Lipids"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.013_bib39","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1194\/jlr.M089250","article-title":"Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver","volume":"59","author":"Pan","year":"2018","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.clnesp.2023.10.013_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104770","article-title":"Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: effects on metabolic parameters, anthropometric indices, and expression of PPAR-\u03b1, UCP1, and UCP2 genes","volume":"156","author":"Tutunchi","year":"2020","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.013_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jcp.29870","article-title":"Expression of NF-\u03baB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: a triple-blind randomized controlled clinical trial","volume":"236","author":"Tutunchi","year":"2021","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.clnesp.2023.10.013_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1144550","article-title":"Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: a randomized controlled trial","volume":"14","author":"Tutunchi","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnesp.2023.10.013_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.appet.2018.05.129","article-title":"Oleoylethanolamide increases the expression of PPAR-\u0391 and reduces appetite and body weight in obese people: a clinical trial","volume":"128","author":"Laleh","year":"2018","journal-title":"Appetite"},{"issue":"5","key":"10.1016\/j.clnesp.2023.10.013_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jada.2005.02.005","article-title":"Comparison of predictive equations for resting metabolic rate in healthy nonobese and obese adults: a systematic review","volume":"105","author":"Frankenfield","year":"2005","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"8","key":"10.1016\/j.clnesp.2023.10.013_bib45","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.013_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif)"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.013_bib47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/obr.12630","article-title":"Oleoylethanolamide: the role of a bioactive lipid amide in modulating eating behaviour","volume":"19","author":"Sihag","year":"2018","journal-title":"Obes Rev : an official journal of the International Association for the Study of Obesity"},{"issue":"8","key":"10.1016\/j.clnesp.2023.10.013_bib48","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Fu","year":"2005","journal-title":"Neuropharmacology"},{"issue":"6953","key":"10.1016\/j.clnesp.2023.10.013_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.clnesp.2023.10.013_bib50","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.013_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metabol"},{"issue":"Pt 1","key":"10.1016\/j.clnesp.2023.10.013_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2006.108506","article-title":"Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders","volume":"574","author":"Viollet","year":"2006","journal-title":"J\u00a0Physiol"},{"issue":"3","key":"10.1016\/j.clnesp.2023.10.013_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/07853890.2010.547211","article-title":"Sirtuin 1 in lipid metabolism and obesity","volume":"43","author":"Schug","year":"2011","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.013_bib54","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.metabol.2015.08.013","article-title":"A\u00a0case-control study: association between serum neuregulin 4 level and non-alcoholic fatty liver disease","volume":"64","author":"Dai","year":"2015","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.clnesp.2023.10.013_bib55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cmet.2012.01.019","article-title":"PPAR\u03b3 agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein","volume":"15","author":"Ohno","year":"2012","journal-title":"Cell Metabol"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.013_bib56","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1172\/JCI96324","article-title":"Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression","volume":"127","author":"Guo","year":"2017","journal-title":"J\u00a0Clin Invest"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772302171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772302171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T01:05:59Z","timestamp":1719363959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545772302171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":56,"alternative-id":["S240545772302171X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.10.013","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}